David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1.52B |
| 2 |
Berkshire Hathaway Class B
BRK.B
|
+$620M |
| 3 |
Pfizer
PFE
|
+$449M |
| 4 |
American International
AIG
|
+$403M |
| 5 |
Walmart Inc
WMT
|
+$392M |
Top Sells
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 9.87% |
| 2 | Financials | 8.04% |
| 3 | Healthcare | 7.54% |
| 4 | Consumer Discretionary | 7.27% |
| 5 | Energy | 6.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
351
Canadian Natural Resources
CNQ
$106B
| $31.3M | 0.06% |
+2,293,542
| New | +$32.9M |
|
352
PUT
Verizon
VZ
$205B
| $31.2M | 0.06% |
+620,700
| New | +$31.7M |
|
353
CALL
3M
MMM
$92.3B
| $31.1M | 0.06% |
+340,262
| New | +$30.9M |
|
354
CALL
Colgate-Palmolive
CL
$72.6B
| $31.1M | 0.06% |
+542,100
| New | +$32.2M |
|
|
MRO
355
DELISTED
Marathon Oil Corporation
MRO
| $31M | 0.06% |
+896,895
| New | +$30.3M |
|
356
Illumina
ILMN
$33.1B
| $30.9M | 0.06% |
+425,043
| New | +$27.2M |
|
357
ConocoPhillips
COP
$162B
| $30.9M | 0.06% |
+509,916
| New | +$31M |
|
358
BorgWarner
BWA
$13.8B
| $30.8M | 0.06% |
+811,581
| New | +$28.5M |
|
|
DD
359
CALL
DELISTED
Du Pont De Nemours E I
DD
| $30.6M | 0.06% |
+613,162
| New | +$31M |
|
360
Range Resources
RRC
$9.59B
| $30.3M | 0.06% |
+392,353
| New | +$29.9M |
|
361
CALL
Bristol-Myers Squibb
BMY
$137B
| $30.3M | 0.06% |
+677,400
| New | +$29.4M |
|
362
Halliburton
HAL
$29.4B
| $30.3M | 0.06% |
+725,510
| New | +$30.3M |
|
363
PUT
Cummins
CMI
$80.9B
| $30.2M | 0.06% |
+278,600
| New | +$31.6M |
|
|
GG
364
DELISTED
Goldcorp Inc
GG
| $30.1M | 0.06% |
+1,218,296
| New | +$34.5M |
|
365
Gilead Sciences
GILD
$181B
| $30M | 0.06% |
+586,568
| New | +$30.6M |
|
366
CALL
Morgan Stanley
MS
$336B
| $30M | 0.06% |
+1,229,400
| New | +$29.2M |
|
367
Eli Lilly
LLY
$1.12T
| $29.9M | 0.06% |
+609,519
| New | +$33.2M |
|
|
SLXP
368
DELISTED
SALIX PHARMACEUTICALS LTD DEL
SLXP
| $29.7M | 0.06% |
+449,468
| New | +$25.7M |
|
369
Duke Energy
DUK
$93.4B
| $29.7M | 0.06% |
+440,252
| New | +$31.1M |
|
370
Advance Auto Parts
AAP
$2.57B
| $29.7M | 0.06% |
+365,706
| New | +$30.3M |
|
371
Carnival Corporation Ltd
CCL
$35.2B
| $29.6M | 0.06% |
+864,226
| New | +$29.3M |
|
372
Micron Technology
MU
$1.09T
| $29.6M | 0.06% |
+2,067,319
| New | +$22.9M |
|
|
XL
373
DELISTED
XL Group Ltd.
XL
| $29.6M | 0.06% |
+976,134
| New | +$30.5M |
|
374
American Electric Power
AEP
$65.8B
| $29.5M | 0.06% |
+658,420
| New | +$31.6M |
|
375
Stellus Capital Investment Corp
SCM
$246M
| $29.3M | 0.06% |
+1,952,302
| New | +$29M |
|
Similar funds
David Shaw's Q2 2013 Portfolio in Review
Q2 2013 is the first quarter with a 13F filing on record for David Shaw, which disclosed 3,939 positions worth $53.2B. Its ten largest holdings account for 15% of the portfolio.
Its largest position is Apple: 99,088,976 shares worth $1.4B.
By sector, the portfolio is most concentrated in Technology at 9.9% of assets, followed by Financials and Healthcare.
- David Shaw's largest Q2 2013 buy was Apple: 99,088,976 shares worth $1.4B.
- David Shaw's ten largest holdings make up 15% of its $53.2B portfolio in Q2 2013.
- David Shaw disclosed 3,939 positions in Q2 2013, its first 13F filing on record.
Based on D.E. Shaw & Co's 13F filing for Q2 2013, filed 14 Aug 2013.